118 related articles for article (PubMed ID: 27085527)
1. Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study.
Lauseker M; Gerlach R; Tauscher M; Hasford J
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1441-7. PubMed ID: 27085527
[TBL] [Abstract][Full Text] [Related]
2. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
Gunnarsson N; Sandin F; Höglund M; Stenke L; Björkholm M; Lambe M; Olsson-Strömberg U; Richter J; Själander A
Eur J Haematol; 2016 Oct; 97(4):387-92. PubMed ID: 26833713
[TBL] [Abstract][Full Text] [Related]
3. Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009.
Penot A; Preux PM; Le Guyader S; Collignon A; Herry A; Dufour V; Monnereau A; Woronoff AS; Troussard X; Pons E; Bordessoule D; Maynadié M
Leuk Lymphoma; 2015 Jun; 56(6):1771-7. PubMed ID: 25535815
[TBL] [Abstract][Full Text] [Related]
4. Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study.
Foulon S; Cony-Makhoul P; Guerci-Bresler A; Delord M; Solary E; Monnereau A; Bonastre J; Tubert-Bitter P
Cancer Med; 2019 Jun; 8(6):3296-3304. PubMed ID: 31038849
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the prevalence and direct medical costs of chronic myeloid leukemia in the I.R. of Iran in the era of tyrosine kinase inhibitors.
Daroudi R; Mirzania M; Nikravanfard N; Sadighi S; Sedighi Z; Zendehdel K
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e416-e422. PubMed ID: 26990676
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
8. [Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study].
Kulikov SM; Vinogradova OIu; Chelysheva EIu; Tishchenko IA; Galaĭko MA; Lazareva OV; Senderova OM; Pepeliaeva VM; Meresiĭ SV; Luchinin AS; Ovsepian VA; Miliutina GI; Gavrilova LV; Avdeeva LB; Neverova AL; Turkina AG
Ter Arkh; 2014; 86(7):24-30. PubMed ID: 25314774
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013.
Beinortas T; Tavorienė I; Žvirblis T; Gerbutavičius R; Jurgutis M; Griškevičius L
BMC Cancer; 2016 Mar; 16():198. PubMed ID: 26956037
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients].
Creutzig U; Ritter J; Zimmermann M; Klingebiel T
Klin Padiatr; 1996; 208(4):236-41. PubMed ID: 8926689
[TBL] [Abstract][Full Text] [Related]
11. Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio.
Clark BR; Ferketich AK; Fisher JL; Ruymann FB; Harris RE; Wilkins JR
Pediatr Blood Cancer; 2007 Nov; 49(6):797-802. PubMed ID: 17366525
[TBL] [Abstract][Full Text] [Related]
12. Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study.
Lauseker M; Gerlach R; Worseg W; Haferlach T; Tauscher M; Hasford J; Hoffmann VS
Eur J Haematol; 2019 Oct; 103(4):362-369. PubMed ID: 31309640
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany.
Rohrbacher M; Berger U; Hochhaus A; Metzgeroth G; Adam K; Lahaye T; Saussele S; Müller MC; Hasford J; Heimpel H; Hehlmann R
Leukemia; 2009 Mar; 23(3):602-4. PubMed ID: 18784744
[No Abstract] [Full Text] [Related]
14. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.
Gunnarsson N; Höglund M; Stenke L; Wållberg-Jonsson S; Sandin F; Björkholm M; Dreimane A; Lambe M; Markevärn B; Olsson-Strömberg U; Wadenvik H; Richter J; Själander A
Leukemia; 2016 Jul; 30(7):1562-7. PubMed ID: 27080811
[TBL] [Abstract][Full Text] [Related]
15. Accurate prediction of the age incidence of chronic myeloid leukemia with an improved two-mutation mathematical model.
Lecca P; Sorio C
Integr Biol (Camb); 2016 Dec; 8(12):1261-1275. PubMed ID: 27801472
[TBL] [Abstract][Full Text] [Related]
16. [Descriptive epidemiology of myeloid leukemia].
Matsuo K; Ito H
Nihon Rinsho; 2009 Oct; 67(10):1847-51. PubMed ID: 19860178
[TBL] [Abstract][Full Text] [Related]
17. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.
Hoffmann VS; Baccarani M; Hasford J; Lindoerfer D; Burgstaller S; Sertic D; Costeas P; Mayer J; Indrak K; Everaus H; Koskenvesa P; Guilhot J; Schubert-Fritschle G; Castagnetti F; Di Raimondo F; Lejniece S; Griskevicius L; Thielen N; Sacha T; Hellmann A; Turkina AG; Zaritskey A; Bogdanovic A; Sninska Z; Zupan I; Steegmann JL; Simonsson B; Clark RE; Covelli A; Guidi G; Hehlmann R
Leukemia; 2015 Jun; 29(6):1336-43. PubMed ID: 25783795
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological data on chronic myeloid leukemia in Asturias, 1972-1986].
Jonte F; Rayón C; Medina J; García Gala J; García Jalón A; Fanjul E; Morante C; Fresno M; Coma A; Arribas M
Sangre (Barc); 1993 Feb; 38(1):1-4. PubMed ID: 8470030
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the target stem-cell population size in chronic myeloid leukemogenesis.
Radivoyevitch T; Ramsey MJ; Tucker JD
Radiat Environ Biophys; 1999 Sep; 38(3):201-6. PubMed ID: 10525957
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of leukemia epidemiology in Northern Tunisia.
Haouas H; Haouas S; Hafsia A
Hematology; 2011 May; 16(3):151-4. PubMed ID: 21669054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
